| Inflammatory Bowel Disease |
1 |
1 |
| Cancer |
0 |
0.94 |
| Cancer Risk |
0 |
0.98 |
| Gastrointestinal Cancer |
0 |
0.74 |
| Nonmelanoma Skin Cancer |
0 |
0.68 |
| Skin Cancer |
0 |
0.67 |
| Hepatocellular Carcinoma |
0 |
0.66 |
| Colorectal Cancer |
0 |
0.63 |
| Child |
0 |
0.99 |
| Biliary Disease |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Colitis |
0 |
0.06 |
| Colonoscopy |
0 |
0.06 |
| Liver |
0 |
0.06 |
| Meta-Analysis |
0 |
0.06 |
| Bowel Preparation |
0 |
0.05 |
| Ulcerative Colitis |
0 |
0.05 |
| Crohn Disease |
0 |
0.04 |
| Primary Sclerosing Cholangitis |
0 |
0.04 |
| Cholangitis |
0 |
0.03 |
| Clinical Guidelines |
0 |
0.03 |
| Europe |
0 |
0.03 |
| Immunosuppressive Therapy |
0 |
0.03 |
| Kidney |
0 |
0.03 |
| Melanoma |
0 |
0.03 |
| Rectum |
0 |
0.03 |